SP1 and plasma cell myeloma: For example, loss of Sp1 in fibromyosarcomas, gliomas, multiple myeloma, lung, pancreatic and colon cancer cells, and rhabdomyosarcomas results in one or more of inhibition of growth, cell cycle progression, survival, migration and invasion [29, 33–43].